• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异恶唑并[3,4 - b]喹啉 - 3,4(1H,9H) - 二酮作为Pim - 1和Pim - 2激酶独特、强效且选择性的抑制剂:化学、生物学活性及分子模拟

Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling.

作者信息

Tong Yunsong, Stewart Kent D, Thomas Sheela, Przytulinska Magdalena, Johnson Eric F, Klinghofer Vered, Leverson Joel, McCall Owen, Soni Niru B, Luo Yan, Lin Nan-horng, Sowin Thomas J, Giranda Vincent L, Penning Thomas D

机构信息

Cancer Research, Global Pharmaceutical R&D, Abbott Laboratories, R47S, AP10, 100 Abbott Park Road, Abbott Park, IL 60064, USA.

出版信息

Bioorg Med Chem Lett. 2008 Oct 1;18(19):5206-8. doi: 10.1016/j.bmcl.2008.08.079. Epub 2008 Aug 28.

DOI:10.1016/j.bmcl.2008.08.079
PMID:18790640
Abstract

A series of isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones were synthesized as potent inhibitors against Pim-1 and Pim-2 kinases. The structure-activity-relationship studies started from a high-throughput screening hit and was guided by molecular modeling of inhibitors in the active site of Pim-1 kinase. Installing a hydroxyl group on the benzene ring of the core has the potential to form a key hydrogen bond interaction to the hinge region of the binding pocket and thus resulted in the most potent inhibitor, 19, with K(i) values at 2.5 and 43.5 nM against Pim-1 and Pim-2, respectively. Compound 19 also exhibited an activity profile with a high degree of kinase selectivity.

摘要

合成了一系列异恶唑并[3,4 - b]喹啉 - 3,4(1H,9H) - 二酮作为针对Pim - 1和Pim - 2激酶的强效抑制剂。构效关系研究从高通量筛选命中物开始,并以Pim - 1激酶活性位点中抑制剂的分子模型为指导。在核心苯环上引入一个羟基有可能与结合口袋的铰链区形成关键的氢键相互作用,从而产生了最有效的抑制剂19,其对Pim - 1和Pim - 2的K(i)值分别为2.5和43.5 nM。化合物19还表现出高度的激酶选择性活性谱。

相似文献

1
Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling.异恶唑并[3,4 - b]喹啉 - 3,4(1H,9H) - 二酮作为Pim - 1和Pim - 2激酶独特、强效且选择性的抑制剂:化学、生物学活性及分子模拟
Bioorg Med Chem Lett. 2008 Oct 1;18(19):5206-8. doi: 10.1016/j.bmcl.2008.08.079. Epub 2008 Aug 28.
2
Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase.鉴定和结构-活性关系的 8-羟基喹啉-7-羧酸衍生物作为 Pim-1 激酶抑制剂。
Bioorg Med Chem Lett. 2010 May 1;20(9):2801-5. doi: 10.1016/j.bmcl.2010.03.061. Epub 2010 Mar 15.
3
Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors.作为Polo样激酶抑制剂的2-氨基异恶唑并吡啶的设计与合成
Bioorg Med Chem Lett. 2008 Oct 1;18(19):5186-9. doi: 10.1016/j.bmcl.2008.08.091. Epub 2008 Aug 29.
4
A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.一项晶体学片段筛选将肉桂酸衍生物鉴定为强效Pim-1抑制剂的起始点。
Acta Crystallogr D Biol Crystallogr. 2011 Mar;67(Pt 3):156-66. doi: 10.1107/S0907444910054144. Epub 2011 Feb 15.
5
Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases.发现新型苯亚甲基-1,3-噻唑烷-2,4-二酮类化合物作为强效和选择性的 PIM-1、PIM-2 和 PIM-3 蛋白激酶抑制剂。
Bioorg Med Chem Lett. 2012 Jul 15;22(14):4599-604. doi: 10.1016/j.bmcl.2012.05.098. Epub 2012 Jun 6.
6
Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase.作为Pim-1激酶抑制剂的取代吡啶酮的鉴定及其构效关系
Bioorg Med Chem Lett. 2007 Mar 15;17(6):1679-83. doi: 10.1016/j.bmcl.2006.12.086. Epub 2007 Jan 4.
7
Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode.命中发现一类新型Pim激酶抑制剂并进行晶体学研究,揭示了一种不同寻常的激酶结合模式。
J Med Chem. 2009 Apr 9;52(7):1814-27. doi: 10.1021/jm801242y.
8
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases.发现3H-苯并[4,5]噻吩并[3,2-d]嘧啶-4-酮作为莫洛尼鼠白血病病毒(PIM)激酶中人类原癌基因原病毒插入位点的强效、高度选择性且口服生物可利用的抑制剂。
J Med Chem. 2009 Nov 12;52(21):6621-36. doi: 10.1021/jm900943h.
9
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.发现新型苯并呋喃-2-羧酸是强效 Pim-1 抑制剂。
Bioorg Med Chem Lett. 2011 May 15;21(10):3050-6. doi: 10.1016/j.bmcl.2011.03.030. Epub 2011 Mar 16.
10
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.结构分析确定咪唑并[1,2 - b]哒嗪类化合物为具有体外抗白血病活性的PIM激酶抑制剂。
Cancer Res. 2007 Jul 15;67(14):6916-24. doi: 10.1158/0008-5472.CAN-07-0320.

引用本文的文献

1
Synthesis of -Alkyl-1,3-dihydro-2,1-benzisoxazoles.α-烷基-1,3-二氢-2,1-苯并异恶唑的合成
Org Lett. 2024 Nov 15;26(45):9722-9727. doi: 10.1021/acs.orglett.4c03509. Epub 2024 Nov 5.
2
Access to β-Alkylated γ-Functionalized Ketones via Conjugate Additions to Arylideneisoxazol-5-ones and Mo(CO)-Mediated Reductive Cascade Reactions.通过对亚芳基异恶唑-5-酮的共轭加成和钼(羰基)介导的还原级联反应制备β-烷基化γ-官能化酮
ACS Omega. 2022 Mar 4;7(10):8808-8818. doi: 10.1021/acsomega.1c07081. eCollection 2022 Mar 15.
3
A review on PIM kinases in tumors.
肿瘤中PIM激酶的综述。
Bioinformation. 2019 Feb 3;15(1):40-45. doi: 10.6026/97320630015040. eCollection 2019.
4
PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.PIM-1促进胰腺癌的恶性发展,并具有诊断和预后价值。
J Exp Clin Cancer Res. 2016 Sep 5;35(1):133. doi: 10.1186/s13046-016-0406-z.
5
Synthesis of 2,1-benzisoxazole-3(1H)-ones by base-mediated photochemical N-O bond-forming cyclization of 2-azidobenzoic acids.通过碱介导的2-叠氮基苯甲酸的光化学N-O键形成环化反应合成2,1-苯并异恶唑-3(1H)-酮
Beilstein J Org Chem. 2016 May 4;12:874-81. doi: 10.3762/bjoc.12.86. eCollection 2016.
6
Pim-1 kinase as cancer drug target: An update.Pim-1激酶作为癌症药物靶点:最新进展
Biomed Rep. 2016 Feb;4(2):140-146. doi: 10.3892/br.2015.561. Epub 2015 Dec 24.
7
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.双激酶-溴结构域抑制剂用于合理设计的多药理学。
Nat Chem Biol. 2014 Apr;10(4):305-12. doi: 10.1038/nchembio.1471. Epub 2014 Mar 2.
8
Clinical and therapeutic relevance of PIM1 kinase in gastric cancer.胃癌中 PIM1 激酶的临床和治疗相关性。
Gastric Cancer. 2012 Apr;15(2):188-97. doi: 10.1007/s10120-011-0097-2. Epub 2011 Oct 13.
9
Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling.Pim-1 激酶通过促进心脏保护性信号来抑制病理性损伤。
J Mol Cell Cardiol. 2011 Oct;51(4):554-8. doi: 10.1016/j.yjmcc.2011.01.004. Epub 2011 Jan 19.
10
The Pim protein kinases regulate energy metabolism and cell growth.Pim 蛋白激酶调节能量代谢和细胞生长。
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):528-33. doi: 10.1073/pnas.1013214108. Epub 2010 Dec 27.